NIOX Group Plc (AIM:NIOX)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 239.58M |
| Revenue (ttm) | 41.80M |
| Net Income (ttm) | 3.70M |
| Shares Out | 397.98M |
| EPS (ttm) | 0.01 |
| PE Ratio | 79.22 |
| Forward PE | 21.24 |
| Dividend | 0.01 (2.08%) |
| Ex-Dividend Date | May 15, 2025 |
| Volume | 278,060 |
| Average Volume | 2,177,908 |
| Open | 60.20 |
| Previous Close | 60.20 |
| Day's Range | 58.13 - 60.20 |
| 52-Week Range | 53.40 - 80.00 |
| Beta | 0.77 |
| RSI | 39.05 |
| Earnings Date | Apr 1, 2025 |
About NIOX Group
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. N... [Read more]
Financial Performance
In 2024, NIOX Group's revenue was 41.80 million, an increase of 13.59% compared to the previous year's 36.80 million. Earnings were 3.70 million, a decrease of -65.42%.
Financial StatementsNews
Private equity firm withdraws takeover bid for NIOX Group
The specialist healthcare and technology investor, which had around €5.5billion in assets under management as of last December, blamed the 'current macro-economic backdrop.'
AIM Market Roundup: Priority Intelligence, Niox, Coral Products
Priority Intelligence, Niox, Coral Products, Uru Metals, Tungsten West are today's biggest risers and fallers on London's AIM market